Medicine price: quote on request. Your total cost is quoted in writing per case.
We give you a written timeline estimate for your case before you commit.
Ask about Enhertu

Is Enhertu available in Saudi Arabia? Status, route and cost

A plain answer for families in Saudi Arabia, checked against FDA, regulator and manufacturer sources on 17 October 2026.

Reviewed by the Reserve Meds clinical operations team on 17 October 2026.

Is Enhertu available in Saudi Arabia?

Yes. Enhertu is registered in Saudi Arabia and listed in SFDA's public Drugs List (checked 17 October 2026). It is a HER2-directed antibody-drug conjugate for several HER2-driven cancers, including breast cancer. Your specialist can prescribe it through a hospital that stocks it, so no named-patient import is normally needed.

  • Registration: Registered in Saudi Arabia: it is listed in the SFDA public Drugs List (entry 1202233232), checked 17 October 2026.
  • Access route: Prescription through a hospital in Saudi Arabia that stocks it.
  • Who acts: your treating specialist and hospital; the hospital pharmacy orders it.
  • Timeline: We give you a written timeline estimate for your case before you commit.
  • Price: Medicine price: quote on request.

Status in Saudi Arabia, with dates

  • Enhertu is listed in the SFDA public Drugs List (entry 1202233232), checked 17 October 2026. The approved uses in Saudi Arabia can differ from the US list, so the oncologist checks the Saudi label. (source)

What Enhertu is

Enhertu (fam-trastuzumab deruxtecan) is made by Daiichi Sankyo (with AstraZeneca). The US FDA first approved Enhertu on 20 December 2019. Its US approvals now include HER2-positive breast cancer (including first-line use with pertuzumab from December 2025 and early breast cancer from May 2026), HER2-low and HER2-ultralow metastatic breast cancer, HER2-mutant lung cancer, HER2-positive stomach cancer, and HER2-positive (IHC 3+) solid tumors (accelerated approval, April 2024).

How it is given: An intravenous (IV) infusion given in an oncology unit, in repeated cycles decided by the oncologist. It carries serious warnings, including lung inflammation (interstitial lung disease), that your oncologist will explain and monitor.

How access works in Saudi Arabia

Because Enhertu is registered, a specialist can prescribe it through a hospital that stocks it, and the hospital pharmacy orders it through the local supply channel. A named-patient import is meant for medicines that are not registered, so it is not the usual route.

If your hospital cannot obtain it, ask the hospital pharmacy why. The reason may be stock, the hospital formulary or funding, and each has a different answer.

Public lists can lag behind decisions, so the hospital pharmacy confirms the current status before treatment is planned.

Who does what

  • Your treating specialist decides whether Enhertu is right for the patient and writes the referral or prescription.
  • The hospital or treatment center orders and gives the medicine, and is responsible for using it safely.
  • The Saudi Food and Drug Authority (SFDA) registers medicines and decides on any import request for a medicine that is not registered.
  • Daiichi Sankyo (with AstraZeneca) makes Enhertu and decides where it can be supplied.
  • Reserve Meds helps your family understand the steps, organizes records and communication, and, where an import is needed, arranges US supply through our licensed wholesale partner. We do not give medical advice.

Documents you will usually need

  • The HER2 test result (HER2-positive, HER2-low or ultralow, or HER2 mutation) that matches the approved use
  • A prescription or treatment plan from the specialist, with the dose and duration
  • Recent clinic notes and laboratory results
  • For an import request: the hospital's request form, its signed declaration of responsibility, written patient consent, and proof of the US FDA approval (we can supply the US prescribing information)

Steps

  1. Assessment. Your specialist confirms that the patient fits the approved use and orders the needed tests.
  2. Prescription. The specialist prescribes it at a hospital that stocks it.
  3. Supply. The hospital pharmacy orders it through the local supply channel.
  4. Treatment. The patient starts treatment with the monitoring the label requires.

Timeline and cost

We give you a written timeline estimate for your case before you commit. The treating center, the regulator and the manufacturer set their own timelines.

Medicine price: quote on request. Your total cost depends on the dose, travel or shipping, import steps and coordination. Your coordination fee is quoted in writing for your case before you commit. No hidden charges.

How Reserve Meds helps

Reserve Meds is a digital health company. Medicines are supplied through a US-licensed pharmaceutical wholesale partner. We coordinate access to FDA-approved medicines only. We help your family understand the route, organize records and communication with the hospital or center, and, where an import is approved, arrange US supply and shipping. We do not prescribe, and we do not decide what the regulator or a treatment center approves.

Ask about Enhertu in Saudi Arabia

Tell us the medicine, your country and a WhatsApp or phone number. We reply within one business day. On WhatsApp we usually reply the same day.

Include the country code, for example +966 or +971.
Message us on WhatsApp

No account needed. We reply within one business day. Your coordination fee is quoted in writing for your case before you commit. No hidden charges.

Frequently asked questions

Is Enhertu registered in Saudi Arabia?

Yes. Enhertu is registered in Saudi Arabia and listed in SFDA's public Drugs List (checked 17 October 2026). Public lists can lag behind registration decisions, so the hospital pharmacy confirms the status in SFDA's system before anything is filed.

How do patients in Saudi Arabia get Enhertu?

It is a HER2-directed antibody-drug conjugate for several HER2-driven cancers, including breast cancer. Your specialist can prescribe it through a hospital that stocks it, so no named-patient import is normally needed.

How long does it take to get Enhertu in Saudi Arabia?

We give you a written timeline estimate for your case before you commit. The treating center, the regulator and the manufacturer set their own timelines, and we tell you honestly what depends on them.

How much does Enhertu cost?

Medicine price: quote on request. Your total cost, including any travel, shipping, import steps and coordination, is quoted in writing for your case before you commit. No hidden charges.

Can Enhertu be sent to our home?

No. Enhertu goes to the hospital that will give it, never to a home address. Reserve Meds is a digital health company. Medicines are supplied through a US-licensed pharmaceutical wholesale partner. We are not a pharmacy.

Sources

Checked on 17 October 2026. Regulator rules and lists change. Your hospital pharmacy or treatment center confirms the current position before anything is filed.

  1. Drugs.com: Enhertu FDA approval history (2019 to May 2026)
  2. Daiichi Sankyo (Business Wire): ENHERTU approved in the US for HER2-low metastatic breast cancer, 5 Aug 2022
  3. SFDA: public Drugs List (all 9,173 entries searched by brand and generic name on 17 Oct 2026)

Related

WhatsApp